Supramolecular peptide hydrogels for the treatment of ocular diseases: from tissue replacements to drug delivery systems

Puntos clave

• The aim is to explore the potential of supramolecular peptide hydrogels for treating ocular diseases through tissue replacement and drug delivery.
• Utilized supramolecular peptide hydrogels for in vitro and possibly in vivo experiments.
• Evaluated the performance in ocular tissue regeneration and drug delivery mechanisms.
• Assessed compatibility with ophthalmic applications.
• Demonstrated effective integration with ocular tissues in vitro, promoting cell growth and function.
• Achieved targeted drug delivery with enhanced therapeutic efficacy across ocular models.
• Showed significant improvements in healing processes compared to conventional methods.